Floatz logo

gx15-070ms

Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma

National Cancer Institute (NCI)Phase 1Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
26/ 100
Competitive Position
89/ 100

Competitive context

62 Active assets in the Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
Shanghai Jiao Tong University School of Medicine
Phase 4BBB
Cyclophosphamide
Shanghai Jiao Tong University School of Medicine
Phase 4BBB
DEXAMETHASONE
National Cancer Institute (NCI)
Phase 2BBB
Bexarotene
Case Comprehensive Cancer Center
Phase 4BBB
FILGRASTIM
City of Hope Medical Center
Phase 4BBB

View all 50 →

Same molecule, other indications

gx15-070ms is also rated in:

follicular lymphomaDormant
B
Indicative ·
57 / 100
View asset →
small cell lung carcinomaDormant
CCC
Indicative ·
55 / 100
View asset →
Hodgkins lymphomaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →